| N˚ | Age* | Sex | Weight** | Hb*** | NSAID | Clinical Syndroms | Within the time limit |
|
| Group Ai |
| |||||||
| 01 | 21 | F‡ | 52 | SC | ibu† | Rhinitis/pruritus/angio-oedema | within 15 mn |
|
| 02 | 16 | M‡‡ | 45 | SC | ibu | Rhinitis/asthma | within 15 to 30 mn |
|
| 03 | 19 | F | 52 | SC | ibu | Hypotension/dyspnoea | within 15 mn |
|
| 04 | 13 | F | 41 | SAFA2 | ibu | Angio-oedema | up to 6 hours |
|
| 05 | 30 | M | 58 | SSFA2 | ibu | Angio-oedema/dyspnoea | within 15 mn |
|
| 06 | 19 | M | 51 | SC | ibu | Asthma/rhinitis | within 15 mn |
|
| 07 | 15 | F | 43 | SSFA2 | ibu | Hypotension/dyspnoea | up to 1 hour |
|
| 08 | 30 | M | 52 | SSFA2 | ibu | Asthma/rhinitis | within 15 mn |
|
| 09 | 33 | M | 57 | SAFA2 | ibu | Rhinitis/pruritus/angio-oedema | within 15 mn |
|
| 10 | 16 | M | 50 | SC | ibu | Hypotension/dyspnoea | within 15 mn |
|
| 11 | 14 | M | 45 | SSFA2 | ibu | Rhinitis/pruritus/angio-oedema | within 15 to 30 mn |
|
| Group Bd | ||||||||
| 12 | 18 | M | 51 | SC | dicl†† | Asthma/rhinitis | within 15 to 30 mn |
|
| 13 | 39 | M | 61 | SSFA2 | dicl | Angio-oedema/pruritus | within 30 mn to 1 hour |
|
| 14 | 27 | F | 55 | SC | dicl | Dyspnoea | within 15 to 30 mn |
|
| 15 | 20 | F | 48 | SAFA2 | dicl | pruritus/Hypotension/dyspnoea | within 15 to 30 mn |
|
| 16 | 28 | M | 59 | SC | dicl | Hypotension/dyspnoea | within 15 to 30 mn |
|
| 17 | 29 | F | 61 | SC | dicl | Hypotension/dyspnoea | within 15 mn |
|
| 18 | 12 | M | 38 | SAFA2 | dicl | Hypotension/dyspnoea | within 15 mn |
|
| 19 | 33 | M | 58 | SC | dicl | Rhinitis | within 15 mn |
|
| 20 | 15 | M | 42 | SSFA2 | dicl | Asthma | within 15 mn |
|
| 21 | 21 | M | 46 | SSFA2 | dicl | Rhinitis/pruritus/angio-oedema | within 30 mn to 1 hour |
|
| 22 | 35 | M | 57 | SSFA2 | dicl | Asthma | within 30 mn to 1 hour |
|